GB2199324A - Process for the preparation of catechols - Google Patents
Process for the preparation of catechols Download PDFInfo
- Publication number
- GB2199324A GB2199324A GB8729268A GB8729268A GB2199324A GB 2199324 A GB2199324 A GB 2199324A GB 8729268 A GB8729268 A GB 8729268A GB 8729268 A GB8729268 A GB 8729268A GB 2199324 A GB2199324 A GB 2199324A
- Authority
- GB
- United Kingdom
- Prior art keywords
- compound
- hydrogen
- formula
- solvent
- preparation
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 238000000034 method Methods 0.000 title claims abstract description 29
- 238000002360 preparation method Methods 0.000 title claims abstract description 11
- 150000005206 1,2-dihydroxybenzenes Chemical class 0.000 title description 6
- 150000001875 compounds Chemical class 0.000 claims abstract description 16
- 239000003054 catalyst Substances 0.000 claims abstract description 11
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 claims abstract description 10
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims abstract description 10
- 239000001301 oxygen Substances 0.000 claims abstract description 10
- 229910052760 oxygen Inorganic materials 0.000 claims abstract description 10
- 125000005843 halogen group Chemical group 0.000 claims abstract description 7
- 239000001257 hydrogen Substances 0.000 claims abstract description 6
- 229910052739 hydrogen Inorganic materials 0.000 claims abstract description 6
- QNQKVMUAFHMBTP-UHFFFAOYSA-N 3-(trifluoromethyl)benzene-1,2-diol Chemical compound OC1=CC=CC(C(F)(F)F)=C1O QNQKVMUAFHMBTP-UHFFFAOYSA-N 0.000 claims abstract description 4
- 125000001589 carboacyl group Chemical group 0.000 claims abstract description 4
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims abstract description 3
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims abstract description 3
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 18
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 claims description 13
- KDLHZDBZIXYQEI-UHFFFAOYSA-N Palladium Chemical compound [Pd] KDLHZDBZIXYQEI-UHFFFAOYSA-N 0.000 claims description 11
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical group OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 claims description 9
- BASFCYQUMIYNBI-UHFFFAOYSA-N platinum Chemical compound [Pt] BASFCYQUMIYNBI-UHFFFAOYSA-N 0.000 claims description 8
- 229910052799 carbon Inorganic materials 0.000 claims description 7
- 239000002904 solvent Substances 0.000 claims description 7
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 claims description 6
- 229910052763 palladium Inorganic materials 0.000 claims description 6
- 125000000217 alkyl group Chemical group 0.000 claims description 4
- 239000010425 asbestos Substances 0.000 claims description 4
- 229910052697 platinum Inorganic materials 0.000 claims description 4
- 229910052895 riebeckite Inorganic materials 0.000 claims description 4
- 229910052731 fluorine Inorganic materials 0.000 claims description 3
- 125000001153 fluoro group Chemical group F* 0.000 claims description 3
- 239000003960 organic solvent Substances 0.000 claims description 3
- LMBFAGIMSUYTBN-MPZNNTNKSA-N teixobactin Chemical compound C([C@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@H](CCC(N)=O)C(=O)N[C@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@H]1C(N[C@@H](C)C(=O)N[C@@H](C[C@@H]2NC(=N)NC2)C(=O)N[C@H](C(=O)O[C@H]1C)[C@@H](C)CC)=O)NC)C1=CC=CC=C1 LMBFAGIMSUYTBN-MPZNNTNKSA-N 0.000 claims description 3
- 150000004945 aromatic hydrocarbons Chemical class 0.000 claims description 2
- 150000002148 esters Chemical class 0.000 claims description 2
- 238000006356 dehydrogenation reaction Methods 0.000 abstract description 7
- 125000004169 (C1-C6) alkyl group Chemical group 0.000 abstract 1
- YDRSQRPHLBEPTP-UHFFFAOYSA-N cyclohexa-3,5-diene-1,2-diol Chemical compound OC1C=CC=CC1O YDRSQRPHLBEPTP-UHFFFAOYSA-N 0.000 abstract 1
- 241000589776 Pseudomonas putida Species 0.000 description 8
- YCIMNLLNPGFGHC-UHFFFAOYSA-N catechol Chemical compound OC1=CC=CC=C1O YCIMNLLNPGFGHC-UHFFFAOYSA-N 0.000 description 8
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 7
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 6
- VZCYOOQTPOCHFL-OWOJBTEDSA-N Fumaric acid Chemical compound OC(=O)\C=C\C(O)=O VZCYOOQTPOCHFL-OWOJBTEDSA-N 0.000 description 6
- 238000006243 chemical reaction Methods 0.000 description 5
- DXOSJQLIRGXWCF-UHFFFAOYSA-N 3-fluorocatechol Chemical compound OC1=CC=CC(F)=C1O DXOSJQLIRGXWCF-UHFFFAOYSA-N 0.000 description 4
- JNYVPTHMUXMTQC-UHFFFAOYSA-N cyclohexa-1,3-diene-1,2-diol Chemical class OC1=C(O)C=CCC1 JNYVPTHMUXMTQC-UHFFFAOYSA-N 0.000 description 4
- 244000005700 microbiome Species 0.000 description 4
- 239000000758 substrate Substances 0.000 description 4
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 3
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- KDYFGRWQOYBRFD-UHFFFAOYSA-N Succinic acid Natural products OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 description 3
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 3
- 238000007792 addition Methods 0.000 description 3
- 238000005273 aeration Methods 0.000 description 3
- 238000001704 evaporation Methods 0.000 description 3
- 230000008020 evaporation Effects 0.000 description 3
- 239000001530 fumaric acid Substances 0.000 description 3
- 239000001963 growth medium Substances 0.000 description 3
- 150000003839 salts Chemical class 0.000 description 3
- ZDQYSKICYIVCPN-UHFFFAOYSA-L sodium succinate (anhydrous) Chemical compound [Na+].[Na+].[O-]C(=O)CCC([O-])=O ZDQYSKICYIVCPN-UHFFFAOYSA-L 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 description 3
- HFVMEOPYDLEHBR-UHFFFAOYSA-N (2-fluorophenyl)-phenylmethanol Chemical class C=1C=CC=C(F)C=1C(O)C1=CC=CC=C1 HFVMEOPYDLEHBR-UHFFFAOYSA-N 0.000 description 2
- GETTZEONDQJALK-UHFFFAOYSA-N (trifluoromethyl)benzene Chemical compound FC(F)(F)C1=CC=CC=C1 GETTZEONDQJALK-UHFFFAOYSA-N 0.000 description 2
- AZQWKYJCGOJGHM-UHFFFAOYSA-N 1,4-benzoquinone Chemical compound O=C1C=CC(=O)C=C1 AZQWKYJCGOJGHM-UHFFFAOYSA-N 0.000 description 2
- PXRKCOCTEMYUEG-UHFFFAOYSA-N 5-aminoisoindole-1,3-dione Chemical class NC1=CC=C2C(=O)NC(=O)C2=C1 PXRKCOCTEMYUEG-UHFFFAOYSA-N 0.000 description 2
- 101150041968 CDC13 gene Proteins 0.000 description 2
- MYMOFIZGZYHOMD-UHFFFAOYSA-N Dioxygen Chemical compound O=O MYMOFIZGZYHOMD-UHFFFAOYSA-N 0.000 description 2
- MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 description 2
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 2
- HEDRZPFGACZZDS-MICDWDOJSA-N Trichloro(2H)methane Chemical compound [2H]C(Cl)(Cl)Cl HEDRZPFGACZZDS-MICDWDOJSA-N 0.000 description 2
- 229940041514 candida albicans extract Drugs 0.000 description 2
- 239000003610 charcoal Substances 0.000 description 2
- 229910001882 dioxygen Inorganic materials 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 239000002609 medium Substances 0.000 description 2
- 239000000243 solution Substances 0.000 description 2
- 239000001384 succinic acid Substances 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- 239000012138 yeast extract Substances 0.000 description 2
- 238000005160 1H NMR spectroscopy Methods 0.000 description 1
- -1 3-fluorocatechol Chemical class 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- 108010023063 Bacto-peptone Proteins 0.000 description 1
- 102000016680 Dioxygenases Human genes 0.000 description 1
- 108010028143 Dioxygenases Proteins 0.000 description 1
- 244000077923 Vaccinium vitis idaea Species 0.000 description 1
- 235000017606 Vaccinium vitis idaea Nutrition 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 239000003905 agrochemical Substances 0.000 description 1
- 229910052921 ammonium sulfate Inorganic materials 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 239000006286 aqueous extract Substances 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 150000001555 benzenes Chemical class 0.000 description 1
- 230000003851 biochemical process Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 239000000872 buffer Substances 0.000 description 1
- KDYFGRWQOYBRFD-NUQCWPJISA-N butanedioic acid Chemical compound O[14C](=O)CC[14C](O)=O KDYFGRWQOYBRFD-NUQCWPJISA-N 0.000 description 1
- 125000004432 carbon atom Chemical group C* 0.000 description 1
- 229940125898 compound 5 Drugs 0.000 description 1
- 239000012050 conventional carrier Substances 0.000 description 1
- 239000013078 crystal Substances 0.000 description 1
- 238000012258 culturing Methods 0.000 description 1
- 230000001419 dependent effect Effects 0.000 description 1
- 229910001873 dinitrogen Inorganic materials 0.000 description 1
- MSJMDZAOKORVFC-SEPHDYHBSA-L disodium fumarate Chemical compound [Na+].[Na+].[O-]C(=O)\C=C\C([O-])=O MSJMDZAOKORVFC-SEPHDYHBSA-L 0.000 description 1
- 238000007323 disproportionation reaction Methods 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 238000000855 fermentation Methods 0.000 description 1
- 230000004151 fermentation Effects 0.000 description 1
- 239000007789 gas Substances 0.000 description 1
- 238000004817 gas chromatography Methods 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 238000004128 high performance liquid chromatography Methods 0.000 description 1
- 238000011065 in-situ storage Methods 0.000 description 1
- 239000000543 intermediate Substances 0.000 description 1
- 238000002955 isolation Methods 0.000 description 1
- 229910052943 magnesium sulfate Inorganic materials 0.000 description 1
- 235000019341 magnesium sulphate Nutrition 0.000 description 1
- 238000001819 mass spectrum Methods 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 239000008057 potassium phosphate buffer Substances 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 239000011541 reaction mixture Substances 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 238000001953 recrystallisation Methods 0.000 description 1
- 238000010992 reflux Methods 0.000 description 1
- 229920006395 saturated elastomer Polymers 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 239000001509 sodium citrate Substances 0.000 description 1
- 235000019294 sodium fumarate Nutrition 0.000 description 1
- 238000000638 solvent extraction Methods 0.000 description 1
- 238000001179 sorption measurement Methods 0.000 description 1
- 238000000859 sublimation Methods 0.000 description 1
- 230000008022 sublimation Effects 0.000 description 1
- 125000001424 substituent group Chemical group 0.000 description 1
- 125000000547 substituted alkyl group Chemical group 0.000 description 1
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 1
- HRXKRNGNAMMEHJ-UHFFFAOYSA-K trisodium citrate Chemical compound [Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O HRXKRNGNAMMEHJ-UHFFFAOYSA-K 0.000 description 1
- 229940038773 trisodium citrate Drugs 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C39/00—Compounds having at least one hydroxy or O-metal group bound to a carbon atom of a six-membered aromatic ring
- C07C39/24—Halogenated derivatives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C37/00—Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom of a six-membered aromatic ring
- C07C37/06—Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom of a six-membered aromatic ring by conversion of non-aromatic six-membered rings or of such rings formed in situ into aromatic six-membered rings, e.g. by dehydrogenation
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Abstract
A process for the preparation of a compound of the general formula <IMAGE> in which each of R<1> and R<2> independently represents a hydrogen or halogen atom or a C1-6 alkanoyl, optionally substituted C1-6 alkyl, optionally substituted phenyl or CN group, provided that when R<2> represents a hydrogen atom, R<1> represents a hydrogen atom, which comprises dehydrogenating the corresponding 1,2-dihydroxycyclohexa-3,5-diene using a dehydrogenation catalyst in the presence of gaseous oxygen. 3-Trifluoromethylcatechol is claimed per se.
Description
PROCESS FOR TES PRELPARATION OF CATEMOLS This invention relates to a process for the preparation of certain catechols from the corresponding dihydroxycyclohexadienes using a dehydrogenation catalyst, and to a novel catechol.
It is kncwn that certain catechols ray be obtained from the corresponding dihydroxycyclohexadienes using a dehydrogenation catalyst under mild conditions. Thus Nakajima et al; Chew. Ber.
1959, 92, 163 discloses the conversion of 1, 2-dihydroxycyclohexadiene to catechol using a dehydrogenation catalyst. 11aug et al; Biochem. Biophys. Res. Common. 1973, 54, 760 discloses the conversion of the conpound of formula
to the corresponding catechol by heating the compound under reflux in water in the presence of palladium on charcoal. Wegst and Lingens, FEMS Microbiol. letters 1983, 17, 341 further discloses the conversion of the compound of formula
to the corresponding catechol under the same reaction conditions as those described in Ilaug et al (loc cit).
Taylor and Brown, Performance Chemicals, November, 1986, pages 18 to 22 disclose the dehydrogenation of dihydrocatechols, e.g. cis-1,2-dihydroxy-3-fluorocyclohexa-3,5-diene using a precious natal catalyst, to afford the equivalent catechols, e.g. 3-fluorocatechol, and also states that catechols are unstable in aerated aqueous systems.
Unfortunately, the catechols prepared using the above-described methods tend to be obtained in relatively low yield. TbLs is because the dinydroxycyclohexadienes disproportionate in the presence of the dehydrogenation catalyst. In other words, some of the dihydroxycyclohexadiene is converzec to dinydroxycyclohexene.
Surprisingly, it has now been found that when the dehydrogenation reaction is effected in the presence of gaseous oxygen, disproportionation is substantially eliminated, and moreover there is no observed oxidation through to undesired quinone.
Accordingly the invention provides a process for the preparation of a compound of the general formula
in which each of R anc R independently represents a hydrogen or halogen atom or a lower alkanoyl, optionally substituted lower alkyl, optionally substituted phenyl or COIN group, provided that when R represents a hydrogen atom, R represents a hydrogen atom, which comprises dehydrogeriating a compound of the general formula
in which R1 and R2 are as defined above by treatment of a compound of formula II with a palladium or platinum catalyst in the presence of gaseous oxygen and an organic solvent at a temperature in the range of 20 to 1200C.
In the process according to the invention, the substituent R is preferably in the para-position relative to R.
Preferably R represents a hydrogen atom.
R preferably represents a hydrogen or halogen atom or a
CF3 or CN group. Mbre preferably, R2 represents a fluorine atom or a CF3 group.
Unless otherwise stated in this specification, any reference to a lower alkanoyl or optionally substituted lower alkyl group preferably means a group having up to 6, for example up to 4 carbon atoms. An optionally substituted alkyl group may be, for example, an unsubstituted alkyl group or a haloalkl group. A halogen atom may be, for example, a fluorine atom.
The solvent employed in the process according to the invention is conveniently selected from an alcohol, e.g.
methanol or ethanol; an ether, e.g. tetrahydrofuran; an aromatic hydrocarbon e.g. benzene or toluene; an ester e.g. ethyl acetate; and mixtures thereof. Preferably an alcohol is employed. When an alcohol is employed, water may be present.
It has been found that the process may advantageously be effected when the concentration of the compound of formula (II) in the organic solvent is in the range of from 0.0001 to 0.05 moles per litre.
The palladium or platinum catalyst employed in the process according to the invention may conveniently be supported on a carrier. Any conventional carrier may be employed, for example carbon or asbestos.
Preferably the process according to the invention is effected at a temperature in the range 40 to 800C, more preferably 50 to 600C.
The gaseous oxygen employed in the process according to the invention may be in the form of pure oxygen gas, but it may very conveniently be in the form of air. The gaseous oxygen can also be generated in situ from hydrogen peroxide.
It has been found that the process according to the invention may conveniently be effected in a continuous manner by passing the solution of the compound of general formula (I) over the catalyst in a stream of gaseous oxygen.
The compounds of formula II may be prepared according to methods known in the art. For example they may be prepared from the corresponding benzene compounds by the action of certain microorganisms such as micro-organisms of the species
Pseudomonas putida, for example as described in European Patent Application publication number EP-A-76606.
According to another aspect of the invention, there is provided a compound of formula
which has the chemical name 3-trifluoromethylcatechol.
It may be prepared by the process according to the present invention, for example using cls-1,2-dihydroxy-3-trifluoro- methylcyclohexa-3,5-diene.
The preparation of cis-1,2-dihydroxy-3-trifluoro- methylcyclohexa-3 , 5-diene is described in our co-pending British patent application number 8616614.
Thus, cis-l , 2dinydroxy-3-trifluoromethylcyclohexa-3, 5- diene may be prepared by culturing a wild type P.putida micro-organism as defined below, supplying trif luoromethyl benzene to the culture in a suitable growth medium and subsequently recovering the cis-1,2-dihydroxy-3trifluoromethylcyclohexa-3,5-diene therefrom.
The P.putida referred to above is that deposited with effect from 6th December, 1985 with the National Collection of
Industrial Bacteria, Torry Research Station, Aberdeen, Scotland and assigned the numerical designation NCIB 12190 and referred to herein as "P.putida NCIB 12190". The isolation of this type of micro-organism has been described by Axcell and Geary,
Biochem. J., (1975), 146, p. 173-183 and Biochem.'J. 136, 927-934.
The culture of P.putida may be initially grown in the presence of any suitable carbon source. However, a preferred carbon source capable of producing a constitutive culture for the desired biochemical process is succinic acid, suitably in the form of a salt such as disodium succinate. Other similar, but less expensive,-carbon sources are those derived from citric acid and fumaric acid, e.g. trisodium citrate and disodium fumarate.
The use of such carbon sources as, for example, salts of succinic, citric and fumaric acid, is particularly useful in that the grown P.putida is found to be constitutive of the dioxygenase required for the process.
The growth medium employed is selected to optimise the yield of cis-l,2-dihydroxy-3-trifluoromethylcyclohexa-3,5-diene.
However the growth medium preferably includes salts of succinic, citric or fumaric acid, as described above for the initial carbon source.
The product compound may be recovered from the resulting fermentation broth by any suitable means, such as adsorption onto granulated charcoal, followed by stripping with a suitable solvent with further purification as necessary dependent on the intended use of the product. Alternative recovery means include solvent extraction.
Compounds of"general formula (I) have applications as intermediates in the preparation of, for example, pharmaceuticals and agrochemicals, as indicated for example by
Taylor and Brown, Performance Chemicals, November, 1986, pages 18 to 22.
Preparation of cis-1,2-dihydroxy-3-trifluoromethylcyclohexa- 3,5-diene in a fermenter using P.putida NCIB 12190
Yeast extract medium (YEM):
10g/l disodium succinate.6H20
2g/l (NH4)S04
3g/l yeast extract (Difco)
0.4g/l MgSO4. 7H20 0.04g/l Bactopeptone in 25 mM potassium phosphate
buffer, final pH 7.0.
8 Litres of YEM in a fermenter were inoculated with a 20h shake culture of P.putida NCIB 12190 (stock slant derived from a shake culture grown on benzene) grown on the same medium (SOml).
The organism was grown at 500rpm; 500ml air/min for 20h, with a continuous feed of concentrated nutrient (disodium succinate (320g) and (NH4)2S04 (64g) in 1 litre of 0.025M KPO4 buffer pH 7.2) at 40ml/h, reaching a cell dry weight of 2.8g/l. The aeration was then increased (550rpm; 750ml air/min) for lhr.
giving an oxygen tension of 20-30% air-saturated.
Benzotrifluoride was then added at 50 "l/min via an HPLC pump.
Using these settings no product was found in the reaction mixture by GLC. It was thus concluded that the combination of low substrate solubility and high aeration was stripping substrate into the exhaust gas before a high enough concentration could be reached for the reaction to occur. To reduce this effect while still maintaining an adequate oxygen tension ( > 308) the stirrer speed was raised to 650rpm while aeration was reduced to 300ml/min. 5g of substrate was added batchwise while still maintaining a flow of SOKl/min. Product formation commenced immediately as judged by CLC and reached 0.3g/l after 60min.Further additions of substrate (5ml) were made at approximately 2h intervals while maintaining the continuous addition (SOyAl/min). The product concentration reached 1.25g/1 after approximately 6h at which point the stirrer failed and the run was terminated. The product was adsorbed onto charcoal followed by stripping in a Soxhlet apparatus (Et20:MeOH 3:1). Evaporation of the solvent yielded about 60ml of aqueous solution of cis-1,2-dihydroxy-3trifluoromethylcyclohexa-3,5-diene which crystallised upon addition of a trace of NaCl. Recrystallisation from Et20: petrol 1:4 yielded approximately 12g ( 1.5g/l) of pure cis-1,2-dihydroxy-3-trifluoromethylcyclohexa-3,5-diene.
The following examples illustrate the invention.
Example 1
Preparation of 3- (trifluoromethyl)catechol Cis-1,2-dihydroxy-3-trifluoromethylcyclohexa-3,5-diene (1.37g) in ethanol (548m1) was trickled at a rate of 4ml/minute, concurrently with a stream of oxygen gas passing at a rate of 20ml/minute, over a loosely packed bed of course palladised asbestos (14% Pd, 0.5g) in a jacketed column at a temperature of 56 C. Ethanol was then passed through the column until no further products were eluted. The eluants were then combined and the solvent was removed by evaporation. The residue was then dissolved in diethyl ether and extracted under nitrogen with aqueous sodium hydroxide. The aqueous extract was then acidified to pH5 and extracted with diethyl ether. The diethyl ether was then removed by evaporation to afford the title compound (0.36g).The product was then purified by sublimation in vacuo to afford the title compound as colourless crystals m.p. 53-56"C.
Mass spectrum: m/z 178 (78%, M+), 158 (100%), 130 (95%).
H-NMR (in CDC13): 5 7.09 (t,2H), 6.90 (t, 1H), 5.8 (broad, 2H; OH) p.p.m.
19 NOR (in CDC13): & -64.9 p.p.m. (d, J 6Hz).
Uv absorption (in ethanol): > max. 286nm ( 3820).
Example 2
Preparation of 3-fluorocatechol
A solution of cis-l,2-dihydroxy-3-fluorocyclohexa-3,5-diene (15mg) in ethanol (12ml) was trickled at a rate of 4ml/minute, concurrently with a stream of air at lO0ml/minute, over a loosely packed bed of coarse palladised asbestos (14% Pd, 0.5g) in a jacketed column held at 56"C. The column was then washed with ethanol until no further products were eluted, and the combined eluants (20.7ml) were analysed by gas chromatography.
The percentage yield of each product in the eluantmeasured by the analysis is given below.
Compound 5 % Yield 3-fluorocatechol 67.0 cis-1,2-dihydroxy-3-fluorocyclohexa-3,5-diene 0 cis-1,2-dihydroxy-3-fluorocyclohex-3-ene 0
For the purpose of comparison, the procedure in Example 2 was repeated using nitrogen gas instead of air. It was found that no cis-1,2-dihydroxy-3-fluorocyclohexa-3,5-diene was present in the eluant. However, cis-1,2-dihydroxy-3fluorocyclohex-3-ene was present in the eluant, the ratio of 3-fluorocatechol to cis-1,2-dihydroxy-3-fluorocyclohex-3-ene being approximately 3:1.
Claims (13)
1. A process for the preparation of a compound of the general formula
in which each of R1 and R2 independently represents a hydrogen or halogen atom or a lower alkanoyl, optionally substituted lower alkyl, optionally substituted phenyl or Con group, provided that when R2 represents a hydrogen atom,
R1 represents a hydrogen atom, which comprises dehydrogenating a compound of the general formula
in which R1 and R2 are as defined above by treatment of a
compound of formula II with a palladium or platinum
catalyst in the presence of gaseous oxygen and an organic
solvent at a temperature in the range of 20 to 1200C.
2. A process as claimed in claim 1, in which R1is in the
para-position relative to R2.
3. A process as claimed in claim 1 or claim 2, in which R1
represents a hydrogen or halogen atom.
4. A process as darned in any one of claims 1 to 3, in which
R2 represents a hydrogen or halogen atom or a CF3 or CN
group.
5. A process as claimed in claim 4, in which R2 represents a fluorine atom or a CF3 3 group.
6. A process as claimed in any one of claims 1 to 5, in which
the gaseous oxygen is in the form of air.
7. A process as claimed in any one of claims 1 to 6, in which
the solvent is selected from an alcohol, an ether, an
aromatic hydrocarbon or an ester.
8. A process as claimed in claim 7, in which the solvent is
methanol or ethanol.
9. A process as claimed in any one of claims 1 to 8, in which
the palladium or platinum catalyst is supported on a carbon
or asbestos carrier.
10. A process as claimed in any one of claims 1 to 9,in which
the temperature is in the range of 40 to 800C.
11. A process as claimed in any one of claims 1 to 10, in which
the compound of formula II is dissolved in the solvent at a
concentration in the range of 0.0001 to 0.05 moles per
litre.
12. A process for the preparation of a compound of formula (I)
as defined in claim 1 substantially as described herein
with reference to the Examples.
13. 3-Trifluoromethylcatechol.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB8630051A GB8630051D0 (en) | 1986-12-16 | 1986-12-16 | Preparation of catechols |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| GB8729268D0 GB8729268D0 (en) | 1988-01-27 |
| GB2199324A true GB2199324A (en) | 1988-07-06 |
| GB2199324B GB2199324B (en) | 1990-06-13 |
Family
ID=10609097
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| GB8630051A Pending GB8630051D0 (en) | 1986-12-16 | 1986-12-16 | Preparation of catechols |
| GB8729268A Expired GB2199324B (en) | 1986-12-16 | 1987-12-15 | Process for the preparation of catechols |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| GB8630051A Pending GB8630051D0 (en) | 1986-12-16 | 1986-12-16 | Preparation of catechols |
Country Status (1)
| Country | Link |
|---|---|
| GB (2) | GB8630051D0 (en) |
Cited By (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0253485A3 (en) * | 1986-06-19 | 1989-05-24 | Imperial Chemical Industries Plc | Cyclic dihydroxy compounds |
| EP0252568A3 (en) * | 1986-07-08 | 1989-05-24 | Shell Internationale Research Maatschappij B.V. | New organofluorine compounds and a biochemical process for their preparation |
| WO1993023356A1 (en) * | 1992-05-12 | 1993-11-25 | Genencor International, Inc. | Process for recovering 2,3-dihydroxy-1-chlorocyclohexa-4,6-diene from aqueous solutions using a solid sorbent |
| US8951630B2 (en) | 2006-12-01 | 2015-02-10 | Rolex S.A. | Ultra-thin hydrophobic and oleophobic layer, method of manufacture and use in watchmaking as an epilame and in mechanical engineering as a barrier film |
-
1986
- 1986-12-16 GB GB8630051A patent/GB8630051D0/en active Pending
-
1987
- 1987-12-15 GB GB8729268A patent/GB2199324B/en not_active Expired
Cited By (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0253485A3 (en) * | 1986-06-19 | 1989-05-24 | Imperial Chemical Industries Plc | Cyclic dihydroxy compounds |
| EP0252568A3 (en) * | 1986-07-08 | 1989-05-24 | Shell Internationale Research Maatschappij B.V. | New organofluorine compounds and a biochemical process for their preparation |
| WO1993023356A1 (en) * | 1992-05-12 | 1993-11-25 | Genencor International, Inc. | Process for recovering 2,3-dihydroxy-1-chlorocyclohexa-4,6-diene from aqueous solutions using a solid sorbent |
| US8951630B2 (en) | 2006-12-01 | 2015-02-10 | Rolex S.A. | Ultra-thin hydrophobic and oleophobic layer, method of manufacture and use in watchmaking as an epilame and in mechanical engineering as a barrier film |
Also Published As
| Publication number | Publication date |
|---|---|
| GB8729268D0 (en) | 1988-01-27 |
| GB8630051D0 (en) | 1987-01-28 |
| GB2199324B (en) | 1990-06-13 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Jian-Xin et al. | Reductive biotransformation of carbonyl compounds—application of fungus, Geotrichum sp. G38 in organic synthesis | |
| EP0088409B1 (en) | Process for preparing 2-keto-l-gulonic acid | |
| CH647490A5 (en) | TERPENOIDS CONTAINING TWO FUNCTIONAL GROUPS, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITION CONTAINING THESE COMPOUNDS. | |
| GB2199324A (en) | Process for the preparation of catechols | |
| Francis et al. | Metabolism of DDT analogues by a Pseudomonas sp | |
| US4981793A (en) | Biological and chemical method for hydroxylating 4-substituted biphenyls and products obtained therefrom | |
| Oritani et al. | Enzymic Resolution of (±)-Unsaturated Cyclic Terpene Alcohols via Asymmetric Hydrolysis of Corresponding Acetates by Microorganisms | |
| EP0193227B1 (en) | Process for the preparation of arylglycidyl ethers and 3-substituted 1-alkylamino-2-propanols | |
| Pietz et al. | Microbial oxygenation of cycloheptyl-N-phenylcarbamate and (±)-trans-2-fluorocycloheptyl-N-phenylcarbamate with beauveria bassiana | |
| EP0252568B1 (en) | New organofluorine compounds and a biochemical process for their preparation | |
| US3676300A (en) | Method for producing monoacyl derivatives of antibiotic t-2636c | |
| EP0193228B1 (en) | Process for producing of 4-(2-methoxyethyl)-phenylglycidyl ether and/or metoprolol | |
| IE44992B1 (en) | 3-hydroxyalkyl (or acetylalkyl)-6,6a,7,8,10,10a-hexahydro -9h-dibenzo(b,d)pyran derivatites | |
| HU201355B (en) | Process for microbiological hydroxylation of quinine, quinidine and their dihydro derivatives | |
| US4877732A (en) | Biochemical process for the preparation of new organofluorine compounds | |
| JP4404710B2 (en) | Method for producing sterol 5-en-3-one and method for analysis | |
| JPS6348518B2 (en) | ||
| US5420361A (en) | Formulation of and dehydration of hydroxylated diphenyl acetylenes | |
| EP1373245B1 (en) | Intermediates for producing spinosyns | |
| US4889804A (en) | Biochemical preparation of alkene derivatives | |
| US4370415A (en) | Process for producing uroporphyrin III | |
| KR960010792B1 (en) | Process for the preparation of macrolide compounds | |
| Nukina et al. | Microbial transformation of 1-and 2-phenyl-1-propenes by the fungus Pyricularia oryzae Cavara | |
| EP0158424B1 (en) | Method for producing hydroquinone | |
| US3488258A (en) | Method of resolving racemic steroids |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PCNP | Patent ceased through non-payment of renewal fee |
Effective date: 19941215 |